IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SIGALA, Sandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.990
EU - Europa 3.515
AS - Asia 1.674
AF - Africa 15
SA - Sud America 15
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.949
CN - Cina 1.008
UA - Ucraina 861
PL - Polonia 556
IT - Italia 527
DE - Germania 455
FR - Francia 293
HK - Hong Kong 285
FI - Finlandia 273
GB - Regno Unito 179
SG - Singapore 174
IE - Irlanda 157
IN - India 99
SE - Svezia 71
BE - Belgio 52
VN - Vietnam 48
CA - Canada 39
CZ - Repubblica Ceca 33
RU - Federazione Russa 29
JP - Giappone 22
TR - Turchia 15
AU - Australia 13
IR - Iran 9
NL - Olanda 9
MU - Mauritius 6
BR - Brasile 5
AR - Argentina 4
CL - Cile 4
EU - Europa 4
GR - Grecia 4
EE - Estonia 3
ES - Italia 3
KR - Corea 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
KG - Kirghizistan 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
SA - Arabia Saudita 1
TN - Tunisia 1
TW - Taiwan 1
Totale 12.226
Salva come PNG Salva come JPEG
Città #
Fairfield 1.045
Woodbridge 835
Jacksonville 651
Ashburn 559
Warsaw 554
Houston 517
Cambridge 421
Seattle 420
Ann Arbor 378
Chandler 339
Wilmington 338
Princeton 291
Hong Kong 280
Nanjing 225
Brescia 170
Dearborn 169
Helsinki 169
Dublin 156
New York 134
Beijing 129
Nanchang 106
Singapore 106
Shenyang 68
Des Moines 60
Changsha 58
Jinan 56
San Diego 55
Shanghai 55
Brussels 51
Dong Ket 48
Hebei 48
West Jordan 46
Tianjin 43
Pune 42
Milan 41
Boardman 32
Jiaxing 30
Kunming 29
Toronto 28
Ningbo 27
Brno 24
London 24
Lancaster 21
Taizhou 21
Verona 21
Los Angeles 19
Rome 19
Zhengzhou 19
Haikou 16
Hangzhou 15
Norwalk 14
Ashiya 11
Kocaeli 11
Lanzhou 10
Monmouth Junction 10
Munich 10
Naples 10
San Francisco 10
San Mateo 10
Ardabil 9
Guangzhou 9
Olomouc 9
New Bedfont 8
Turin 8
Washington 8
Augusta 7
Redwood City 7
Fuzhou 6
Livorno 6
Melbourne 6
Acton 5
Bari 5
Changchun 5
Chicago 5
Dallas 5
Koka 5
Leawood 5
North York 5
Phoenix 5
Sabbio Chiese 5
Vicenza 5
Kilburn 4
Nürnberg 4
Orange 4
Vignate 4
Bologna 3
Borås 3
Brooklyn 3
Canberra 3
Catania 3
Centro 3
Detroit 3
Gumyojicho 3
Hefei 3
Lappeenranta 3
Lonato 3
Madrid 3
Padova 3
Rockville 3
San Donà Di Piave 3
Totale 9.303
Salva come PNG Salva come JPEG
Nome #
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 231
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 215
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 207
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 181
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 179
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 163
Immunotherapy failure in adrenocortical cancer: where next? 157
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 154
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 145
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 144
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 143
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 142
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 142
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 139
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 136
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 134
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 134
Palbociclib inhibits proliferation of human adrenocortical tumor cells 131
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 130
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 128
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 126
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 123
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 122
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 122
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 121
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 117
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 117
A new pharmacological approach to the facilitation of acetylcholine transmission. 116
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 116
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 111
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 109
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 108
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 106
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 105
Dopamine receptors are present in rat and human esophagus 105
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 105
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 104
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 103
Sex-related variations in serum nerve growth factor concentration in humans. 103
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 103
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 102
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 101
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 100
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 100
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 100
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 100
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 99
Different neurotransmitter systems are involved in the development of esophageal achalasia 98
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 98
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 98
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 98
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 97
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 96
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 96
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 96
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 96
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 95
Nerve growth factor signaling in prostate health and disease. 94
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 93
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 93
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 93
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 93
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 92
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 91
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 89
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 86
Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. 86
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 85
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 85
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 84
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 81
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 81
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 80
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 79
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 78
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 76
MUSCARINIC RECEPTOR MESSENGER RNAs ARE DIFFERENTIALLY EXPRESSED IN MALE AND FEMALE NORMAL HUMAN BLADDER 74
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 73
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 72
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 69
Phenotype changes of prolactinomas 68
SUPPRESSION OF TELOMERASE, RE-EXPRESSION OF KAI1 AND ABROGATION OF TUMORIGENICITY BY NGF IN PROSTATE CANCER CELL LINES. 68
D-1 and D-2 dopamine receptors in rat esophagus: biochemical and functional characterization 68
Identification of Dopamine receptors in rat and human esophagus 66
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 65
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 64
role of acetylcholine as a growth factor: focus on human urinary bladder 62
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 62
Opposite effects of D2 and D3 dopamine receptors in learning and memory in the rat 62
D-1 and D-2 dopamine receptors are present in human lower esophageal sphincter 61
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 58
Induction of the unfolded protein response by α-synuclein in experimental models of Parkinson's disease. 57
Un'esperienza didattica di promozione della salute per le matricole dei Corsi di Laurea della Facoltà di Medicina e Chirurgia 57
LA STIMOLAZIONE COLINERGICA DETERMINA AUMENTO DELLA PROLIFERAZIONE NELLA LINEA CELLULARE UROTELIALE UROTSA 57
Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach 57
Epidermal growth factor promotes uncoupling from the adenylate cyclase of the human D2 receptor expressed in GH4C1 cells 56
Stimulation of muscarinic receptors induces cell proliferation of human detrusor muscle cell 56
Adrenocortical carcinoma 56
Inhibition of aldosterone secretion in patients with congestive heart failure: role of dopamine and dopaminergic drugs. 55
Caratterizzazione biochimica e molecolare dei recettori dopaminergici nell'apparato urinario dell'uomo 55
Totale 10.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.693 485 105 130 396 208 443 400 406 265 491 137 227
2020/20212.298 74 229 100 285 122 250 108 259 310 220 224 117
2021/20221.261 120 186 38 68 15 58 63 76 61 154 112 310
2022/20231.077 190 62 48 81 83 260 8 90 134 14 39 68
2023/20241.417 72 39 126 101 82 256 49 67 284 75 34 232
2024/202524 24 0 0 0 0 0 0 0 0 0 0 0
Totale 12.528